Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Janus Henderson Biotech Innovation Master Fund Limited investment portfolio

Janus Henderson Biotech Innovation Master Fund Limited has made numerous investments in companies such as Artios Pharma, Ottimo Pharma, and Quell Therapeutics within the Healthcare & Life Sciences sector.

vc
Portfolio
4
Team
0

Portfolio (4)

CompanySectorCitySourceLast confirmed on
Artios Pharma Limited
Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours.
Healthcare & Life SciencesCambridgeConfirmed2025-12-28
Ottimo Pharma Limited
Ottimo Pharma develops bifunctional, dual‑paratopic antibodies that simultaneously target PD‑1 and VEGFR2 to treat cancer, aiming to extend the lives of patients with malignancies. It is a clinical‑stage biotechnology company focused on advancing these novel immuno‑oncology therapeutics through clinical development.
Healthcare & Life SciencesSandwichConfirmed2026-01-21

Sign up to see the full portfolio

+2 more companies

Sign up

Shareholding changes (4)

Janus Henderson Biotech Innovation Master Fund Limited's positions across portfolio companies
2026
2025

Sign up free to see when this investor has bought or sold shares.

+2 more changes

Sign up